journal article Aug 01, 2005

The Effect of 17β- estradiol on invasion by the ovarian clear cell adenocarcinoma cell line ES - 2 and the molecular mechanism involved

View at Publisher Save 10.1007/bf02819537
Topics

No keywords indexed for this article. Browse by subject →

References
17
[1]
Ho CM, Chien TY, Shih BY, et al. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Gynecol Oncol. 2003;88:394–399. 10.1016/s0090-8258(02)00156-7
[2]
Purdie DM, Bain CJ, Siskind V, et al. Hormone replacement therapy and risk of epithelial ovarian cancer. Br J Cancer. 1999;81:559–563. 10.1038/sj.bjc.6690731
[3]
Zanetta GM, Webb MJ, Li H, et al. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol. 2000;79:18–22. 10.1006/gyno.2000.5905
[4]
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

Eduard Batlle, Elena Sancho, Clara Francí et al.

Nature Cell Biology 2000 10.1038/35000034
[5]
The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

Amparo Cano, Mirna A. Pérez-Moreno, Isabel Rodrigo et al.

Nature Cell Biology 2000 10.1038/35000025
[6]
Yokoyama K, Kamata N, Fujimoto R, et al. Increased invasion and matrix metalloproteinase-2 expression by Snailinduced mesenchymal transition in squamous cell carcinomas. Int J Oncol. 2003;22:891–898.
[7]
Fujita N, Jaye DL, Kajita M, et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 2003;113:207–219. 10.1016/s0092-8674(03)00234-4
[8]
Holinka CF, Hata H, Gravanis A, et al. Effects of estradiol on proliferation of endometrial adenocarcinoma cells (Ishikawa line). J Steroid Biochem. 1986;25:781–786. 10.1016/0022-4731(86)90308-0
[9]
Swan SH. Intrauterine exposure to diethylstilbestrol: longterm effects in humans. APMIS. 2000; 108:793–804. 10.1111/j.1600-0463.2000.tb00001.x
[10]
Fujimura M, Hidaka T, Kataoka K, et al. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma. Am J Surg Pathol. 2001;25:667–672. 10.1097/00000478-200105000-00016
[11]
Nusslein-Volhard C, Wieschaus E, Kluding H. Mutations affecting the pattern of the larval cruticle in Drosophila melanogaster. I. Zygotic loci on the second chromosome. Wilhelm Roux’s Arch Dev Biol. 1984;193:267–282. 10.1007/bf00848156
[12]
Corbo JC, Erives A, Di Gregorio A, et al. Dorsoventral patterning of the vertebrate neural tube is conserved in a protochordate. Development 1997;124:2335–2344. 10.1242/dev.124.12.2335
[13]
Chen S, Zhou D, Yang C, et al. Modulation of aromatase expression in human breast tissue. J Steroid Biochem Mol Biol. 2001 ;79:35–40. 10.1016/s0960-0760(01)00132-7
[14]
Cowley SM, Hoare S, Mosselman S, et al. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem. 1997;272: 19858. 10.1074/jbc.272.32.19858
[15]
Pace P, Taylor J, Suntharalingam S, et al. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem. 1997;272: 25832. 10.1074/jbc.272.41.25832
[16]
Gaub MP, Bellard M, Scheuer I, et al. Activation of the ovalbumin gene by the estrogen receptor involves the fos jun complex. Cell. 1990;63:1267. 10.1016/0092-8674(90)90422-b
[17]
Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ER alpha and ER beta at API sites. Science. 1997;277:1508. 10.1126/science.277.5331.1508